FDA regulation of CBD products faces new challenges as the market develops.
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Pennsylvania law prevents people who use drugs from testing for fentanyl and avoiding overdoses.
Scholars discuss the challenges of promoting antibiotic development and preserving existing drugs.
Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.
A new report offers recommendations for extending telehealth treatment of opioid use disorder.
Scholars critique the regulation of psychedelic substances and propose reforms for medical research and use.
Experts consider how regulators can make drugs affordable without hindering research and development.
Critics of a proposed rule to import drugs from Canada cite safety concerns and other potential problems.
A federal task force proposes regulatory solutions to mitigate drug shortages.
Brazil has recently made efforts to streamline the introduction and distribution of drugs.
This Saturday Seminar explores how regulation addresses and affects opioid use and addiction.